Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Rudnick

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
CNS Oncology|March 7, 2020
Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndromeThomas Nelson, Jethro Hu, Serguei Bannykh, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2020
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive ProlactinomasOdelia Cooper, Vivien S Bonert, Jeremy Rudnick, et al.
Plos One|April 6, 2012
Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide eraChristine Carico, Miriam Nuño, Debraj Mukherjee, et al.
Seminars in Oncology|September 13, 2014
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe)Maciej M Mrugala, Herbert H Engelhard, David Dinh Tran, et al.
Oncotarget|March 3, 2016
Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategiesJoanne Xiu, David Piccioni, Tiffany Juarez, et al.
Science Translational Medicine|August 16, 2019
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trialE Antonio Chiocca, John S Yu, Rimas V Lukas, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
CNS Oncology|March 7, 2020
Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndromeThomas Nelson, Jethro Hu, Serguei Bannykh, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2020
EGFR/ErbB2-Targeting Lapatinib Therapy for Aggressive ProlactinomasOdelia Cooper, Vivien S Bonert, Jeremy Rudnick, et al.
Plos One|April 6, 2012
Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide eraChristine Carico, Miriam Nuño, Debraj Mukherjee, et al.
Seminars in Oncology|September 13, 2014
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe)Maciej M Mrugala, Herbert H Engelhard, David Dinh Tran, et al.
Oncotarget|March 3, 2016
Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategiesJoanne Xiu, David Piccioni, Tiffany Juarez, et al.
Science Translational Medicine|August 16, 2019
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trialE Antonio Chiocca, John S Yu, Rimas V Lukas, et al.
International Journal of Cancer|June 21, 2018
Profiles of brain metastases: Prioritization of therapeutic targetsSherise D Ferguson, Siyuan Zheng, Joanne Xiu, et al.
Pageof 1